TerminatedNot Applicable

A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients

Stopped: Due to clear evidence of the intervention's effectiveness on a pre-planned interim analysis

Spain165 participantsStarted 2024-04-04

Plain-language summary

Design, implementation and analysis of an allergy assessment and management model beta-lactams in hospitalized patients

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years * Ability to understand the study after reading the patient information sheet (Appendix II) and providing signed consent for participation (Appendix III: informed consent form). * Patients with a reported allergy to penicillin and/or cephalosporins that has not been investigated or with inconclusive prior testing. Exclusion Criteria \- None

What they're measuring

Proportion of patients hospitalized in which the penicillin allergy label is removed

Timeframe: At enrollment time

Trial details

NCT IDNCT07194824

SponsorAlthaia Xarxa Assistencial Universitària de Manresa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-23

View on ClinicalTrials.gov More Allergy Drug trials